- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02358122
Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh (RIGHT)
Study Overview
Status
Intervention / Treatment
Detailed Description
A dietary intervention study designed as a randomized, controlled, parallel intervention of 6-weeks duration. A total of 75 participants will be included in the study and randomly allocated to one of three interventions (refined wheat, whoelgrain wheat or wholegrain rye). The randomization will be stratified according to sex and sex-specific median habitual cereal dietary fibre intake (16g/d for men and 13g/d for women). The randomization will be done by means of a randomization generator of the webpage (http://www.randomization.com). Recruitment and randomization will take place continuously during the study period, and therefore randomization will be done as mixed block randomization.
During the intervention study, participants are instructed to substitute all cereal products (e.g. bread, breakfast cereals, pasta) of their diet with the provided study products. The amount of provided study products will match the average intake of carbohydrate-rich products of the Danish population, which corresponds to ~200g of bread and cereal products per day. The participants will eat the study products in an ad libitum manner and b instructed to avoid other cereals in their diet including cake, biscuits, ready made meals and fast foods with the exception of White rice whis is allowed 1-2 times per week.
Clinincal examinations including anthropometric assessment, fecal, urine and fastign blood sampling, dietary assessment and a meal challenge will be done before (week 0) and after (week 6) the intervention. At timepoints week 0, 2, 4 and 6 questionnaires will be filled in concerning satisfaction with diet and gastrointestinal symptoms.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
• Age: 30 - 65 years
- Body mass index (BMI): 25 - 32 kg/m2
- Weight stable (<3 kg weight change during the last 6 months)
- Apparently healthy
- Informed consent signed
- Freezer capacity for 2 weeks bread provision
- Can attend all visits required for the study
Exclusion Criteria:
• Smoking on a daily basis
- Lactating (or lactating within 6 weeks prior to study start), pregnant (or pregnant within 3 months prior to study start) or wish to become pregnant during the study
- Diagnosed with any form of diabetes or CVD
- Reported chronic GI disorders
- Antibiotic treatment 3 month before study start and during the study
- Use of pre- or probiotic 1 month before study start and during the study
- Lack of cooperation and adherence to the protocol
- Use of prescription medication will be evaluated on an individual basis
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Refined wheat
Refined wheat grain, a variety of cereal foods providing no wholegrain
|
A variety of cereal foods providing 0g/day wholegrain
|
Experimental: Wholegrain wheat
Wholegrain wheat grain, a variety of cereal foods providing >100g wheat wholegrain/day
|
A variety of cereal foods providing >100g/day wholegrain from wheat
|
Experimental: Wholegrain rye
Wholegrain rye grain, a variety of cereal foods providing >100g rye wholegrain/day
|
A variety of cereal foods providing >100g/day wholegrain from rye
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Gastrointestinal symptoms evaluated by questionnaires (100mm visual analogue scales)
Time Frame: Change from 0 to 6 weeks
|
Subjective sensations of gastrointestinal symptoms evaluated by questionnaires (100mm visual analogue scales)
|
Change from 0 to 6 weeks
|
Gut microbiota composition assessed using 16S in a single fecal sample
Time Frame: Change from 0 to 6 weeks
|
Gut microbiota compostion assessed using 16S in a single fecal sample
|
Change from 0 to 6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anthropometric masures
Time Frame: Change from 0 to 6 weeks
|
Body weight and waist circumference, saggital abdominal diameter and body composition (fat mass and fat free mass assessed using DEXA)
|
Change from 0 to 6 weeks
|
Blood pressure
Time Frame: Change from 0 to 6 weeks
|
Diastolic and systolic blood pressure and heart rate assessed twice using an automated apparatus
|
Change from 0 to 6 weeks
|
Blood lipids, fasting concentrations of total, LDL and HDL cholesterol and triglyerides
Time Frame: Change from 0 to 6 weeks
|
Fasting concentrations of total, LDL and HDL cholesterol and triglyerides
|
Change from 0 to 6 weeks
|
Glucose metabolism, fasting concentrations of glucose, insulin and HbA1C as calculation of HOMA-IR
Time Frame: Change from 0 to 6 weeks
|
Fasting concentrations of glucose, insulin and HbA1C as calculation of HOMA-IR
|
Change from 0 to 6 weeks
|
Low-grade inflammation, fasting concentrations of hsCRP, IL-6, IL-10, and TNF-a
Time Frame: Change from 0 to 6 weeks
|
Fasting concentrations of hsCRP, IL-6, IL-10, and TNF-a
|
Change from 0 to 6 weeks
|
Appetite sensation
Time Frame: Change from 0 to 6 weeks
|
Fasting and postprandial (every 30 minutes for 240 minutes) sensation of hunger, satiety, fullness, prospective food intake, thirst and well being
|
Change from 0 to 6 weeks
|
Breath hydrogen assessed using a Hydrolyzer
Time Frame: Change from 0 to 6 weeks
|
Fasting and postprandial (every 30 minutes for 240 minutes) concentrations of H2 in exhaled breath assessed using a Hydrolyzer
|
Change from 0 to 6 weeks
|
Short chain fatty acids, fecal concentrations of short chain fatty acids
Time Frame: Change from 0 to 6 weeks
|
Fecal concentrations of short chain fatty acids
|
Change from 0 to 6 weeks
|
Fecal pH
Time Frame: Change from 0 to 6 weeks
|
Fecal pH assessed in homogenized fecal sample
|
Change from 0 to 6 weeks
|
Intestinal permeability, assessed by urinary excretion of lactulose and mannitol
Time Frame: Change from 0 to 6 weeks
|
Intestinal permeability is assessed by urinary excretion of lactulose and mannitol for 4 hours and 24 hours following an oral load of 10g lactulose and 2 g mannitol
|
Change from 0 to 6 weeks
|
Zonulin, fasting concentrations in plasma
Time Frame: Change from 0 to 6 weeks
|
Fasting concentrations of zonulin in plasma
|
Change from 0 to 6 weeks
|
Dietary intake, a weighted 4-day food record
Time Frame: Change from 0 to 6 weeks
|
a weighted 4-day food record will be used to assess energy intake and macronutrient (protein, fat, carbohydrates and dietaru fiber) composition
|
Change from 0 to 6 weeks
|
Compliance, measured by fasting plasma alkylresorcinol concentrations will be used as a biomarker of wholegrain wheat and rye intake
Time Frame: Change from 0 to 6 weeks
|
Fasting plasma alkylresorcinol concentrations will be used as a biomarker of wholegrain wheat and rye intake
|
Change from 0 to 6 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Christensen L, Vuholm S, Roager HM, Nielsen DS, Krych L, Kristensen M, Astrup A, Hjorth MF. Prevotella Abundance Predicts Weight Loss Success in Healthy, Overweight Adults Consuming a Whole-Grain Diet Ad Libitum: A Post Hoc Analysis of a 6-Wk Randomized Controlled Trial. J Nutr. 2019 Dec 1;149(12):2174-2181. doi: 10.1093/jn/nxz198.
- Vuholm S, Nielsen DS, Iversen KN, Suhr J, Westermann P, Krych L, Andersen JR, Kristensen M. Whole-Grain Rye and Wheat Affect Some Markers of Gut Health without Altering the Fecal Microbiota in Healthy Overweight Adults: A 6-Week Randomized Trial. J Nutr. 2017 Nov;147(11):2067-2075. doi: 10.3945/jn.117.250647. Epub 2017 Sep 27.
- Suhr J, Vuholm S, Iversen KN, Landberg R, Kristensen M. Wholegrain rye, but not wholegrain wheat, lowers body weight and fat mass compared with refined wheat: a 6-week randomized study. Eur J Clin Nutr. 2017 Aug;71(8):959-967. doi: 10.1038/ejcn.2017.12. Epub 2017 Mar 22.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H-1-2014-062
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Diseases
-
Umeå UniversityRecruitingFunctional Gastrointestinal DisorderSweden
-
The University of Texas Medical Branch, GalvestonCompletedGastrointestinal Disorders, Functional
-
Campus Bio-Medico UniversityRecruitingGastrointestinal Cancer | Gastrointestinal Hemorrhage | Gastrointestinal Lesions | Gastrointestinal Injury | Gastrointestinal Perforation | Gastrointestinal UlcerItaly
-
Chang Gung Memorial HospitalNew Bellus EnterprisesUnknownNeoplasm | Functional Gastrointestinal DisorderTaiwan
-
Massachusetts General HospitalEnrolling by invitationGastrointestinal Dysfunction | Gastrointestinal DiseaseUnited States
-
Dr Anne PayneUniversity of LondonUnknownFunctional Gastrointestinal Disorders in ChildrenUnited Kingdom
-
Jiangxi University of Traditional Chinese MedicineThe First Affiliated Hospital of Nanchang University; Second Affiliated Hospital... and other collaboratorsCompletedGastrointestinal DiseaseChina
-
Indiana UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingFunctional Gastrointestinal DisordersUnited States
-
Beth Israel Deaconess Medical CenterCompleted
-
Nationwide Children's HospitalCompletedFunctional Gastrointestinal DisordersUnited States
Clinical Trials on Refined wheat
-
Purdue UniversityCompletedObesity | Diabetes Mellitus, Type 2 | Appetitive BehaviorUnited States
-
University of CopenhagenBARILLA G. e R. Fratelli S.p.A., Parma, Italy; the European Commission in the...Completed
-
Swedish University of Agricultural SciencesCompleted
-
Wageningen UniversityUniversity Medical Center Groningen; Cereal Partners Worldwide; TNO; Nederlands... and other collaboratorsCompleted
-
Peking UniversityCompleted
-
King's College LondonCompleted
-
USDA Beltsville Human Nutrition Research CenterUnited States Department of Agriculture (USDA)Completed
-
Swedish University of Agricultural SciencesUppsala UniversityCompleted
-
Fudan UniversitySwedish University of Agricultural Sciences; Shanghai Zhongye HospitalActive, not recruitingH. Pylori Infections | Non-communicable DiseasesChina